Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormone replacement therapy trials: an update.

Claire S Duvernoy1, Lori Mosca

  • 1Preventive Cardiology, New York Presbyterian Hospital, 622 West 168th Street, PH 10-203B, New York, NY 10032, USA.

Current Atherosclerosis Reports
|February 2, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management and Outcomes of Patients Undergoing Cardiovascular Evaluation Across Health Care Systems: Comparison of Community Care and Integrated Veterans Affairs Health Care.

Journal of the American Heart Association·2025
Same author

Sex Disparities in the Management of Acute Coronary Syndromes: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

Journal of the American Heart Association·2024
Same author

2022 ACC Health Policy Statement on Career Flexibility in Cardiology: A Report of the American College of Cardiology Solution Set Oversight Committee.

Journal of the American College of Cardiology·2022
Same author

Online Educational Tools for Caregivers of People with Dementia: A Scoping Literature Review.

Canadian geriatrics journal : CGJ·2021
Same author

Perspectives of Racially and Ethnically Diverse U.S. Cardiologists: Insights From the ACC Professional Life Survey.

Journal of the American College of Cardiology·2021
Same author

Gender Differences in the Pursuit of Cardiac Electrophysiology Training in North America.

Journal of the American College of Cardiology·2021
Same journal

Overview of Novel Mechanisms in Obesity Pharmacotherapy and Implications for Cardiovascular Disease: A Narrative Review.

Current atherosclerosis reports·2026
Same journal

Artificial and Other Non-Nutritive Sweeteners, the Microbiome, and Cardiometabolic Health.

Current atherosclerosis reports·2026
Same journal

Single-cell Technologies in Atherosclerosis: Uncovering Cellular Heterogeneity, Mechanisms, and Therapeutic Opportunities.

Current atherosclerosis reports·2026
Same journal

Primary Prevention of Dyslipidemia: 10 Practice-Changing Takeaways from the 2026 ACC/AHA Multisociety Guideline.

Current atherosclerosis reports·2026
Same journal

Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.

Current atherosclerosis reports·2026
Same journal

Familial Hypercholesterolemia in Women: Diagnosis, Treatment, and Cardiovascular Outcomes Across the Lifespan.

Current atherosclerosis reports·2026
See all related articles

Recent hormone replacement therapy (HRT) trials contradict earlier findings on cardiovascular risk. For healthy women, noncardiac factors should guide HRT decisions due to potential adverse effects.

Area of Science:

  • Cardiovascular Health
  • Hormone Replacement Therapy (HRT)
  • Postmenopausal Women's Health

Background:

  • Observational studies suggested cardiovascular benefits of hormone therapy (HT).
  • Recent randomized trials show inconsistent cardiovascular risk outcomes with HRT.
  • Emerging data links HRT to adverse prothrombotic or proinflammatory effects in women with existing heart disease.

Purpose of the Study:

  • To evaluate the current understanding of hormone replacement therapy's cardiovascular implications in postmenopausal women.
  • To inform clinical decisions regarding HRT use, particularly in healthy women and those with established coronary heart disease.

Main Methods:

  • Review and synthesis of recent randomized trials on hormone replacement therapy.
  • Analysis of emerging evidence regarding HRT's effects on cardiovascular outcomes.

Related Experiment Videos

  • Consideration of alternative therapies like phytoestrogens and selective estrogen receptor modulators (SERMs).

    • Main Results:

    • Randomized trials of HRT do not consistently support the cardiovascular risk reduction observed in prior observational studies.
    • Evidence suggests potential prothrombotic and proinflammatory risks associated with HRT in specific patient groups.
    • Alternative therapies show promise for cardiovascular risk factors, but clinical outcomes are yet undetermined.

    Conclusions:

    • The decision to use HRT in healthy postmenopausal women should prioritize noncardiac factors pending further cardiovascular data.
    • HRT's role in women with established coronary heart disease requires careful consideration due to potential adverse events.
    • Further research is needed to clarify the long-term clinical impact of HRT and its alternatives on cardiovascular health.